Organization
Amerex Group, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Amerex Group, Inc.
... agreement to develop and commercialize a next generation sequencing (NGS)-based companion diagnostic (CDx) assay. Under the terms of the agreement, ArcherDX will develop and seek ...
... an agreement for the development, regulatory support and commercialization of companion diagnostics (CDx), with an initial focus on CDx development for pemigatinib (INCB54828), Incyte's selective ...
... demonstrated its superior performance compared to reference methods. - Partnership tests: Second CDx (Companion Diagnostics) partnership signed with Amgen for the development of Idylla(TM) CDx ...
... is unacceptably contaminated according to health department limits. Two newer labs — CDX Analytics in Salem and EVIO Labs in Southbridge — employ a faster, ...
... target of doubling volumes in 2018. - Menu partnerships: Second companion diagnostics (CDx) agreement signed with Amgen. Partnership signed with Immunexpress to develop and commercialize ...
... Foundation Medicine, Inc. (NASDAQ:FMI) today announced that FoundationOne CDx(TM), the first U.S. Food and Drug Administration (FDA) approved comprehensive genomic profiling ...
... Food & Drug Administration (FDA) under the parallel review process for FoundationOne CDx, the first broad comprehensive genomic profiling test for all solid tumors incorporating ...
... The partnership focuses on development, regulatory support and commercialization of companion diagnostics (CDx) that will be included in updates to FoundationOne CDx(TM). FoundationOne CDx is ...
... tested positive for germline BRCA mutations as determined by Myriad's FDA-approved BRACAnalysis CDx test. As presented at SABCS, the results demonstrated that patients with gBRCA+ ...
... CDx, Foundation Medicine's comprehensive companion diagnostic assay for personalised oncology care1. FoundationOne CDx supports physicians in clinical decision-making by providing a report that describes the ...
Subscribe now for full coverage on Amerex Group, Inc.
Start My Free Trial